World's Best Scientists 2026 revealed!
Richard O. Williams

Richard O. Williams

D-Index & Metrics

Immunology

D-Index
77
Citations
15674
World Ranking
1859
National Ranking
165

Richard O. Williams publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard O. Williams sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 242 publications — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Richard O. Williams D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard O. Williams sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 77 D-Index — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Richard O. Williams is affiliated with the University of Oxford in the United Kingdom. Their research primarily spans the fields of Medicine and Neuroscience, with a significant focus on Immunology, Biological Psychiatry, Behavioral Neuroscience, Rheumatology, and Molecular Biology.

The scientist's work covers several key topics, including:

  • Tryptophan and brain disorders
  • Stress Responses and Cortisol
  • Rheumatoid Arthritis Research and Therapies
  • Immune Cell Function and Interaction
  • Immune Response and Inflammation
  • Bipolar Disorder and Treatment
  • Mast cells and histamine

Richard O. Williams has published extensively in a range of scientific journals. Frequent publication venues include:

  • Frontiers in Immunology
  • Journal of Autoimmunity
  • Lara D. Veeken
  • British Journal of Oral and Maxillofacial Surgery
  • Cancer Research

Some recent papers authored or co-authored by Williams include:

  • "IDO and Kynurenine Metabolites in Peripheral and CNS Disorders," 2020, Frontiers in Immunology
  • "Modulation of T cells by tryptophan metabolites in the kynurenine pathway," 2023, Trends in Pharmacological Sciences
  • "High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging," 2021, Science Advances
  • "Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation-Cancer Interface," 2023, Cancers
  • "An integrated cytokine and kynurenine network as the basis of neuroimmune communication," 2022, Frontiers in Neuroscience

The scientist has collaborated frequently with several researchers, including:

  • Trevor W. Stone
  • Felix I. L. Clanchy
  • Louise M. Topping
  • Joy Ogbechi
  • A Smith Mith

Best Publications

  • Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

    Richard O. Williams;Marc Feldmann;Ravinder N. Maini

  • Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen‐induced arthritis

    Claudia Mauri;Richard O. Williams;Marita Walmsley;Marc Feldmann

  • Interleukin-10 inhibition of the progression of established collagen-induced arthritis.

    Marita Walmsley;Peter D. Katsikis;Erika Abney;Sarah Parry

  • Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease.

    Ravinder N. Maini;Michael J. Elliott;Fionula M. Brennan;Richard O. Williams

  • RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy

    Shlomo Nedvetzki;Erez Gonen;Nathalie Assayag;Reuven Reich

  • Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.

    Richard O. Williams;Lesley J. Mason;Marc Feldmann;Ravinder N. Maini

  • Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells

    Clare A. Notley;Julia J. Inglis;Saba Alzabin;Fiona E. McCann

  • IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production

    Katrina Blazek;Hayley L. Eames;Miriam Weiss;Adam J. Byrne

  • Protocol for the induction of arthritis in C57BL/6 mice.

    Julia J Inglis;Egle Simelyte;Fiona E McCann;Gabriel Criado

  • Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll‐like receptors

    Sandra M. Sacre;Mino Medghalchi;Bernard Gregory;Fionula Brennan

  • Suppression of collagen-induced arthritis by continuous administration of IL-4.

    A C Horsfall;D M Butler;L Marinova;P J Warden

  • Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade.

    Julia J. Inglis;Clare A. Notley;David Essex;Alex W. Wilson

  • Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain.

    Kay E. McNamee;Annika Burleigh;Annika Burleigh;Annika Burleigh;Luke L. Gompels;Marc Feldmann

  • Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway.

    Adam P. Cribbs;Alan Kennedy;Henry Penn;Jordan E. Read

  • Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis.

    L Marinova-Mutafchieva;R O Williams;K Funa;R N Maini

  • Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis

    Fiona E McCann;Andrew C Palfreeman;Melanie Andrews;Melanie Andrews;Dany P Perocheau

  • Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy.

    Richard O. Williams;Lilia Marinova-Mutafchieva;Marc Feldmann;Ravinder N. Maini

  • Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway

    Saba Alzabin;Sonya M Abraham;Taher E Taher;Andrew Palfreeman

  • Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.

    Kostas A. Triantaphyllopoulos;Richard O. Williams;Hitakshi Tailor;Yuti Chernajovsky

  • IDO and Kynurenine Metabolites in Peripheral and CNS Disorders

    Yi-Shu Huang;Joy Ogbechi;Felix I. Clanchy;Richard O. Williams

  • RHAMM, a receptor for hyaluronan-mediated motility, compensates for CD44 in inflamed CD44-knockout mice: A different interpretation of redundancy (vol 101, pg 18081, 2004)

    S Nedvetzki;E Gonen;N Assayag;R Reich

Frequent Co-Authors

Marc Feldmann
Marc Feldmann University of Oxford
Ravinder N. Maini
Ravinder N. Maini Imperial College London
Peter C. Taylor
Peter C. Taylor University of Oxford
Fionula M. Brennan
Fionula M. Brennan University of Oxford
Claudia Mauri
Claudia Mauri University College London
Patrick J. Venables
Patrick J. Venables University of Oxford
Andrew P. Cope
Andrew P. Cope King's College London
Isabel Roditi
Isabel Roditi University of Bern
Ewa M. Paleolog
Ewa M. Paleolog University of Oxford
Christopher D. Buckley
Christopher D. Buckley University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related online degrees in nursing and healthcare can open diverse career opportunities. Accelerated nurse practitioner programs online are a popular choice for students seeking a fast-track path into advanced clinical roles. These programs help bridge the gap between foundational nursing knowledge and specialized practice areas.

Many students without prior nursing experience start with the best online BSN programs for non nurses, which provide comprehensive training and prepare graduates for licensure. If you’re looking to quickly enter the field, exploring the easiest ABSN programs to get into can be a strategic choice, offering accessible pathways with flexible formats.

For practicing Family Nurse Practitioners (FNPs) aiming to shift focus, acute care certification for FNP is a valuable credential. It equips professionals with critical skills to manage complex patient conditions in acute settings, expanding career prospects significantly.

Whether transitioning within nursing specialties or beginning a new healthcare career, these online options create flexible, efficient routes toward contributing to immunology-related healthcare fields.

Best Scientists Citing Richard O. Williams

Trending Scientists

Recently Published Articles